In the samples obtained from an initially responding patient, both ZEB1 and TWIST1 were present at low levels and then increased significantly in the relapsed tumor after treatment, in terms of both the intensity and percentage of positive cells, which changed from 10% to 80% (patient 4, Figs 3D and EV1B). This evidence concerns the gene ZEB1 and neoplasm.